Literature DB >> 11334675

Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis.

A Meddeb-Garnaoui1, S Gritli, S Garbouj, M Ben Fadhel, R El Kares, L Mansour, B Kaabi, L Chouchane, A Ben Salah, K Dellagi.   

Abstract

HLA-DRB1, -DQB1, TNFalpha, TNFbeta, HSP70-2 and HSP70-hom genetic polymorphisms were analyzed in 156 unrelated patients who developed mediterranean visceral leishmaniasis (MVL) due to Leishmania infantum, and 154 unrelated healthy controls, who have got asymptomatic infection with this parasite and were selected on the basis of a positive leishmanin skin test (LST). A significantly reduced frequency of HLA-DR2 was observed among MVL patients (16.1%), compared with controls (26.3%) (relative risk = 0.54; p = 0.04). HLA-DR2/DR13 as well as HLA-DQB1*0201/- genotype frequencies were significantly lower in patients vs controls (relapse rate = 0.17 and 0.46, respectively; p < 0.05). However, using Bonferroni correction, none of these associations remained significant. No association was found, between either the -308 base pair TNFalpha gene polymorphism or the NcoI polymorphism in the first intron of the TNFbeta gene and susceptibility to MVL. Analysis of PstI and NcoI polymorphisms in the coding region of HSP70-2 and HSP70-hom genes, respectively, revealed a significantly higher frequency of homozygotes for the HSP70-2/PstI negative allele, among patients (21.8%) vs controls (12.6%) (relapse rate = 1.94; p = 0.04). Again, this result was not significant after using Bonferroni correction. These results do not support association between susceptibility to MVL and the MHC class II and class III loci analyzed in this study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334675     DOI: 10.1016/s0198-8859(01)00237-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism.

Authors:  Rupert J Quinnell; Lorna J Kennedy; Annette Barnes; Orin Courtenay; Christopher Dye; Lourdes M Garcez; Marie-Anne Shaw; Stuart D Carter; Wendy Thomson; William E R Ollier
Journal:  Immunogenetics       Date:  2003-03-20       Impact factor: 2.846

2.  Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection.

Authors:  S M B Jeronimo; A K B Holst; S E Jamieson; R Francis; D R A Martins; F L Bezerra; N A Ettinger; E T Nascimento; G R Monteiro; H G Lacerda; E N Miller; H J Cordell; P Duggal; T H Beaty; J M Blackwell; M E Wilson
Journal:  Genes Immun       Date:  2007-08-23       Impact factor: 2.676

3.  Association of HSP70-hom genetic variant with prostate cancer risk.

Authors:  Sana Sfar; Hamadi Saad; Faouzi Mosbah; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

4.  Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major.

Authors:  Besma E C Babay; Hechmi Louzir; Chahnaz Kebaïer; Samir Boubaker; Koussay Dellagi; Pierre-André Cazenave
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 5.  Genetics and visceral leishmaniasis: of mice and man.

Authors:  J M Blackwell; M Fakiola; M E Ibrahim; S E Jamieson; S B Jeronimo; E N Miller; A Mishra; H S Mohamed; C S Peacock; M Raju; S Sundar; M E Wilson
Journal:  Parasite Immunol       Date:  2009-05       Impact factor: 2.280

6.  Human HLA-DR transgenes protect mice from fatal virus-induced encephalomyelitis and chronic demyelination.

Authors:  Moses Rodriguez; Laurie Zoecklein; Jason G Kerkvliet; Kevin D Pavelko; Louisa Papke; Charles L Howe; Larry R Pease; Chella David
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

Review 7.  HLA and infectious diseases.

Authors:  Jenefer M Blackwell; Sarra E Jamieson; David Burgner
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

8.  Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis.

Authors:  Michaela Fakiola; Amy Strange; Heather J Cordell; E Nancy Miller; Matti Pirinen; Zhan Su; Anshuman Mishra; Sanjana Mehrotra; Gloria R Monteiro; Gavin Band; Céline Bellenguez; Serge Dronov; Sarah Edkins; Colin Freeman; Eleni Giannoulatou; Emma Gray; Sarah E Hunt; Henio G Lacerda; Cordelia Langford; Richard Pearson; Núbia N Pontes; Madhukar Rai; Shri P Singh; Linda Smith; Olivia Sousa; Damjan Vukcevic; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas W Wood; Mary E Wilson; Panos Deloukas; Leena Peltonen; Frank Christiansen; Campbell Witt; Selma M B Jeronimo; Shyam Sundar; Chris C A Spencer; Jenefer M Blackwell; Peter Donnelly
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

9.  Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.

Authors:  Javier Quilez; Verónica Martínez; John A Woolliams; Armand Sanchez; Ricardo Pong-Wong; Lorna J Kennedy; Rupert J Quinnell; William E R Ollier; Xavier Roura; Lluís Ferrer; Laura Altet; Olga Francino
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

10.  Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.

Authors:  Tapan Bhattacharyya; Duncan E Bowes; Sayda El-Safi; Shyam Sundar; Andrew K Falconar; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Marleen Boelaert; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.